Your Search Results

      • Trusted Partner

        Bastei Lübbe AG

        Bastei Lübbe AG, based in Cologne, Germany, is a large, both traditional and modern company in the German publishing industry, specializing in the publication of books, audio books and eBooks with fiction and popular science content. The company's core business also includes periodically published novel books. The product range of the twelve imprints of the media company currently comprises a total of around 3,600 titles from the fiction, non-fiction, children's and youth book sectors. International and national bestselling authors such as Ken Follett, Dan Brown, Jeff Kinney, Rebecca Gablé, Petra Hülsmann, Andreas Eschbach, Timur Vermes and many more have published their books at the Cologne publishing house, some of them for decades. Die in Köln ansässige Bastei Lübbe AG ist ein großes, sowohl traditionsreiches wie auch modernes Unternehmen im deutschen Verlagswesen, das auf die Herausgabe von Büchern, Hörbüchern und eBooks mit belletristischen und populärwissenschaftlichen Inhalten spezialisiert ist. Zum Kerngeschäft des Unternehmens gehören auch die periodisch erscheinenden Romanhefte. Das Angebot der zwölf Verlage und Imprints des vor mehr als 60 Jahren gegründeten Medienhauses umfasst derzeit insgesamt rund 3.600 Titel aus den Bereichen Belletristik, Sach-, Kinder- und Jugendbuch. Internationale und nationale Bestsellerautoren wie Ken Follett, Dan Brown, Jeff Kinney, Rebecca Gablé, Petra Hülsmann, Andreas Eschbach, Timur Vermes und viele mehr veröffentlichen ihre Bücher zum Teil seit Jahrzehnten im Kölner Verlagshaus.

        View Rights Portal
      • Media Vaca

        Since 1998, Media Vaca has specialized in the invention of highly illustrated books designed for readers of all ages. The care and hard work which is required by every new project only permit the publication of three titles per year.

        View Rights Portal
      • Trusted Partner
        January 2019

        HIV/AIDS, Second Edition

        by Patrick G. Guilfoile, Ph.D.

        Human immunodeficiency virus (HIV) is a viral infection that can develop into acquired immunodeficiency syndrome (AIDS). More than 1 million Americans are infected with HIV/AIDS, and the Centers for Disease Control estimate that 15 percent of them are unaware of it. There is no cure or vaccine for HIV/AIDS, but it can be managed through proper medication and a healthy lifestyle. HIV/AIDS, Second Edition describes the symptoms, diagnosis, treatment, and prevention of HIV/AIDS, the newest research in the field, and future prospects for controlling the disease.  Chapters include: What Are HIV and AIDS? The History of HIV/AIDS The Biology of HIV/AIDS Diagnosis and Treatment of HIV/AIDS Prevention of HIV/AIDS Attempts to Develop a Vaccine for HIV/AIDS HIV/AIDS: Future Prospects and Concerns.

      • Trusted Partner
        January 2020

        Ebola and Marburg Viruses, Third Edition

        by Patrick G. Guilfoile, Ph.D. and Tara C. Smith, Ph.D.

        Ebola virus and Marburg virus are related viruses that cause hemorrhagic fevers—illnesses marked by severe bleeding, organ failure, and, in many cases, death. These viruses are native to Africa, where sporadic outbreaks have occurred for decades. Ebola and Marburg Virus, Second Edition takes a look at the nature and origins of these viruses, transmission, treatment, and current vaccine research. Chapters include: A Modern Plague The Emergence of Marburg Virus Ebola in Africa and Beyond Characteristics of Filoviruses Ecology of the Viruses Detection and Treatment Developing a Vaccine Other Hemorrhagic Fevers.

      • Trusted Partner
        January 2021

        Anthrax, Third Edition

        by Alan Hecht, D.C.

        Anthrax became a household word in 2001 when spores of the bacterium were delivered via the U.S. Postal Service by unknown terrorists. The very mention of anthrax has the potential to set off a panic, but what is anthrax, what are its symptoms, and why is it so dangerous? Anthrax, Third Edition looks at the history of this deadly disease, from biblical times to the present, and investigates possible treatments to protect humans against it. This revised edition provides relevant, up-to-date information about anthrax and what doctors and scientists are doing to combat this threat. Chapters include: A Cloud of Death The Fifth Plague Human Anthrax Deadly Letters (Outbreak 2001) Diagnosing and Treating Anthrax Anthrax Vaccine Anthrax and Bioterrorism.

      • Trusted Partner
        January 2021

        Smallpox, Second Edition

        by Brian R. Shmaefsky, Ph.D. and Kim R. Finer, Ph.D.

        Before its eradication, smallpox was responsible for millions of deaths throughout history. The disease is unique to humans, caused by one of two virus variants, Variola major and Variola minor. Early symptoms include fever, fatigue, headache, muscle pain, nausea, and vomiting. After 12 to 15 days, lesions appear in the mouth, and then spread to the skin a day or two later. At this point, the disease can take several different courses. Historically, the overall fatality rate is 30%. This revised edition of Smallpox, Second Edition discusses the history and epidemiology of the disease, plus the amazing story of its eradication. Although the disease has not been seen in its natural form in more than 40 years, the future of smallpox, and its potential use as a biological weapon, are of great concern. Chapters and topics include: History of Smallpox Elimination of Smallpox Smallpox in the Americas The Smallpox Virus Symptoms Treatment Vaccine Development The Bioweapons Threat New Concerns and Future Prospects.

      • Trusted Partner
        Business, Economics & Law
        September 2020

        Tourism and Gender-based Violence

        Challenging Inequalities

        by Paola Vizcaino-Suárez, Heather Jeffrey, Claudia Eger

        Gender-based violence (GBV) in travel and tourism is embedded within wider social structures of gender inequalities and discrimination. Even though it is pertinent to study GBV in all its forms, this book focuses on the multiple and interconnected manifestations of violence that women/girls encounter in tourism consumption and production (physical, sexual, emotional or socio-economic), while seeking to open the debate on violence against sexual minorities (LGBT) and discussing men/boys as victims and perpetrators of GBV. By engaging in a critical exploration of the theoretical landscape of GBV and case studies on GBV and sexual harassment, the book adopts a multidisciplinary perspective drawing on feminist, intersectional and post-colonial frameworks, bringing together contributions from academics and practitioners across the globe.

      • Trusted Partner

        Half the Quilt(Picture Book Edition)

        by Xiaoxiang Film Group Co., Yang Fei

        Half of the Quilt(Picture Book Edition) is based on the movie Heart for Heart (produced by Xiaoxiang Film Group and directed by Meng Qi). In October 1934, the fifth anti-encirclement failed, the Central Red Army evacuated the Soviet Union and began the Long March. The Red Army field hospital was bombed by enemy planes and suffered heavy casualties. Dong Xiuyun, a female soldier who stayed at the field hospital to look after the wounded, decided to take the wounded with her and chase the troops. Dong Xiuyun took in the soldiers of the various units who were left alone along the road, forming a special team. After the team came to Shazhou Village, the three female Red Army lived in Xu Xiexiu's house. When parting, Dong Xiuyun cut the only one quilt in half to Xu Xiexiu. This book nourishes the young people's spiritual world with red culture, inherits the red gene, and allows the spirit of the Long March to be passed on from generation to generation among children.

      • Trusted Partner
        January 2020

        Tuberculosis, Third Edition

        by Alan Hecht, D.C.

        Tuberculosis is a serious infection caused most commonly by the Mycobacterium tuberculosis bacterium or one of three other organisms of the Mycobacterium genus. Tuberculosis primarily affects the lungs, but the infection can attack any part of the body. If left untreated, tuberculosis can cause lung damage, meningitis, and even death; the World Health Organization reported 1.5 million deaths due to tuberculosis in 2018. Those at highest risk for tuberculosis include those with weakened immune systems and those in areas of the world with poor nutrition and poor access to health care. Most cases of tuberculosis can be treated with a combination of medications that are taken for several months, but failure by many people to fully follow their course of treatment has led to the emergence of drug-resistant strains of tuberculosis bacteria. Tuberculosis, Third Edition covers the history, causes, and treatments of this potentially deadly disease. Chapters include: Tuberculosis Throughout Time Robert Koch, Selman Waksman, and the Near Defeat of Tuberculosis The Tuberculosis Bacterium Consumption: What Happens Once You Become Infected Transmission from Organism to Organism The Immune Response to Tuberculosis Infection Screening for and Diagnosis of Tuberculosis The BCG Vaccine Treatment of Tuberculosis I: Sanatoriums and Early Drug Treatments Treatment of Tuberculosis II: Modern Drug Therapy The Human Immunodeficiency Virus and Tuberculosis

      • Trusted Partner
        January 2020

        Streptococcus (Group A), Third Edition

        by Brian R. Shmaefsky, Ph.D. and Tara C. Smith, Ph.D.

        Group A streptococci (Streptococcus pyogenes) are probably best known for causing streptococcal pharyngitis, or strep throat. But they also cause more kinds of disease than any other species of bacteria. Group A streptococci are responsible for diseases that range from mild skin conditions to scarlet fever to rheumatic fever to the devastating and sometimes deadly necrotizing fasciitis, commonly known as "flesh-eating bacteria." This revision of Streptococcus (Group A) examines the history, epidemiology, and future prospects for the ongoing battle against group A streptococci, and provides up-to-date information on research breakthroughs and the latest outbreaks of group A diseases. Updates include information on antibiotic resistance, current research on scarlet fever, and the progress on a vaccine. Chapters include: One Bacterium, Many Different Diseases Diagnosis and Treatment of the Group A Streptococcus Superficial Infections: Streptococcal Pharyngitis and Impetigo Scarlet Fever Resurgence of an Old Pathogen: Invasive Streptococcal Diseases Post-Streptococcal Complications Virulence Factors of Group A Streptococci Vaccine Prospects and the Future of the Group A Streptococcus.

      • Trusted Partner
        January 2019

        Lyme Disease, Third Edition

        by Len Yannielli and Alan Hecht, D.C.

        Lyme disease is caused by a bacterium carried by ticks. Early Lyme disease symptoms are flu-like, including fatigue, sore throat, swollen lymph glands, and neck and back pain. A red, bullseye rash can also occur. After the bacteria spreads through the body, additional symptoms may include joint and muscle pain, and meningitis, Bell's palsy, and nervous system involvement may arise. Most cases of Lyme disease can be treated with a course of antibiotics, according to the Centers for Disease Control and Prevention, and prevention includes using insect repellant and removing ticks promptly from skin and clothing. This updated edition of Lyme Disease covers the latest research about the disease, its treatment, and its effects on the human body. Chapters include: An Introduction to Lyme Disease The History of Lyme Disease The Lyme Disease Bacteria Ticks and Lyme Disease Ecology and Lyme Disease Lyme Disease Epidemiology The Tests and Treatments for Lyme Disease The Lyme Vaccine.

      • Trusted Partner
        November 2020

        One Health

        The Theory and Practice of Integrated Health Approaches

        by Jakob Zinsstag, Esther Schelling, Lisa Crump, Maxine Whittaker, Marcel Tanner, Craig Stephen

        One Health, the concept of combined veterinary and human health, has now expanded beyond emerging infectious diseases and zoonoses to incorporate a wider suite of health issues. Retaining its interdisciplinary focus which combines theory with practice, this new edition illustrates the contribution of One Health collaborations to real-world issues such as sanitation, economics, food security and vaccination programmes. It includes more non-infectious disease issues and climate change discussion alongside revised case studies and expanded methodology chapters to draw out implications for practice. Promoting an action-based, solutions-oriented approach, One Health: The Theory and Practice of Integrated Health Approaches highlights the lessons learned for both human and animal health professionals and students.

      • Trusted Partner
        The Arts
        January 2019

        Realist film theory and cinema

        The nineteenth-century Lukácsian and intuitionist realist traditions

        by Ian Aitken

        'Realist film theory and cinema' embraces studies of cinematic realism and 19th century tradition, the realist film theories of Lukács, Grierson, Bazin and Kracauer, and the relationship of realist film theory to the general field of film theory and philosophy. This is the first book to attempt a rigorous and systematic application of realist film theory to the analysis of particular films. The book suggests new ways forward for a new series of studies in cinematic realism, and for a new form of film theory based on realism. It stresses the importance of the question of realism both in film studies and in contemporary life. Aitken's work will be of interest to scholars and advanced students of film studies, literary studies, media studies, cultural studies and philosophy.

      • Trusted Partner
        Medicine
        September 2017

        Antimicrobial Peptides

        Discovery, Design and Novel Therapeutic Strategies

        by Guangshun Wang

        Antimicrobial peptides (AMPs) have attracted extensive research attention worldwide. Harnessing and creating AMPs synthetically has the potential to help overcome increasing antibiotic resistance in many pathogens. This new edition lays the foundations for studying AMPs, including a discovery timeline, terminology, nomenclature and classifications. It covers current advances in AMP research and examines state-of-the-art technologies such as bioinformatics, combinatorial libraries, high-throughput screening, database-guided identification, genomics and proteomics-based prediction, and structure-based design of AMPs. Thoroughly updated and revised, this second edition contains new content covering: defensins; cathelicidins; anti-MRSA, antifungal, antiviral, anticancer and antibiofilm strategies; combined treatments; adjuvants in vaccines; advances in AMP technologies that cover surface coating to prevent biofilm formation; nanofiber encapsulation technologies for delivery and sustained release; and understanding innate immunity and the basis for immune boosting to overcome obstacles in developing AMPs into therapeutic agents. Written and reviewed by a group of established investigators in the field, Antimicrobial Peptides is a valuable resource for postgraduate students, researchers, educators, and medical and industrial personnel.

      • Trusted Partner
        January 2021

        Yellow Fever, Second Edition

        by Brian R. Shmaefsky, Ph.D.

        Caused by a virus that is spread through the bite of an infected mosquito, yellow fever gets its name for the jaundice it causes its victims. This hemorrhagic illness has plagued humans throughout history, and before the development of a yellow fever vaccine, the mortality rate from this disease was high. Tropical nations now prevent epidemic yellow fever levels through vaccination, and travelers to these areas are advised to take precautions. Yellow Fever, Second Edition explores both the historical and epidemiological aspects of this disease. Colorful photographs, maps, and illustrations provide important explanations of various aspects of yellow fever, and information on vaccination, treatment, prevention, and up-to-date statistics on worldwide incidences are provided. Chapters include: The Yellow Fever Disease Disease Course and Epidemiology Diagnosis, Treatment, and Prevention Yellow Fever and Other Modern Plagues The Impact of Diseases on History Future Directions in Controlling Viral Diseases.

      • Trusted Partner
        Technology, Engineering & Agriculture
        January 2017

        The UK Pesticide Guide 2017

        by Martin A Lainsbury

        The UK Pesticide Guide 2017 has 7 new active ingredient profiles. Two are confirmed as available in 2017 while 5 are currently only listed as Products also Registered (PARs). The two available are: - cyantraniliprole for insect control in headed brassicas - halauxifen-methyl +/- fluroxypyr for broad-leaved weed control in cereals. The five awaiting confirmation are: - buprofezin for insect control in protected Solonaceae - penhoxamid for weed control in grain maize and winter oilseed rape - Pepino Mosaic Virus for suppression of viral diseases in protected tomatoes - Pythium oligandrun M1 for disease control in spring barley, wheat and oilseed rape - Tembotrione for weed control in maize and sweetcorn. In addition, hazard precautions have been upgraded and the roll out of extended buffer zones, for some products, continues with many products re-approved under new MAPP numbers. There are also: - 7 new herbicide profiles - 4 in the main section and 3 as PARs - 8 new fungicide profiles - 6 in the main section and 2 as PARs - 1 new plant growth regulator (PGR) combination and 1 new molluscicide. In the main section of the Guide 8 herbicide profiles (tepraloxydim approval expires 30/11/ 2016), 17 fungicides (including prochloraz), 4 insecticides and 1 PGR are no longer included. ; The UK Pesticide Guide 2017 has 7 new active ingredient profiles. In addition, hazard precautions have been upgraded and the roll out of extended buffer zones, for some products, continues with many products re-approved under new MAPP numbers. ; 1: Crop/Pest Guide Index2: Pesticide Profiles3: Products also registered4: Adjuvants5: Key Information for Users of Pesticides6: Suppliers of Pesticides and Adjuvants

      • Trusted Partner
        January 2020

        Streptococcus (Group B), Second Edition

        by Brian R. Shmaefsky, Ph.D. and Tara C. Smith, Ph.D.

        Group B streptococcus is a type of bacteria that mostly affects infants, the elderly, and those with immune systems compromised due to other diseases. It can cause severe infection and meningitis. Approximately 19,000 cases occur annually in the United States, and it's the most common cause of life-threatening infections in newborns. This informative book enhances readers' understanding of this disease by examining how this type of bacteria lives and is transmitted, and explaining how it can be prevented and treated. Chapters include:   History of Group B Streptococcal (GBS) Disease Group B Streptococcus (GBS) Group B Streptococcus (GBS) Diagnosis and Treatment Group B Streptococcus (GBS) with Pregnancy and Other Conditions Group B Streptococcus (GBS) Infection in Animals Group B Streptococcus (GBS) Virulence Factors Vaccine Prospects for Group B Strepotococcus (GBS)

      • Trusted Partner
      • Trusted Partner
        February 1966

        Parteifinanzierung und Grundgesetz.

        Rechtsfragen von Rechenschaftspflicht und Staatszuschüssen.

        by Plate, Heiko

      • Trusted Partner
        December 1966

        Ernst Beling als Strafrechtsdogmatiker.

        Seine Lehren zur Begriffs- und Systembildung.

        by Plate, Hartwig

      Subscribe to our

      newsletter